Article · 4 May 2026
Short communicationPublished 28 Jul 2023
Clinical Observation of Sodium Oligomannate Capsules in the Treatment of Cognitive Dysfunction in Parkinson's Disease
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
To observe the effect of sodium oligomannate capsules on cognitive dysfunction in Parkinson's disease. 120 patients with cognitive dysfunction were randomly divided into, 60 in treatment and 60 in control group and given sodium oligomannate capsules dose of 5 mg/d, 450 mg/d respectively and compared cognitive function scores (mini-mental state examination, Montreal cognitive assessment). After treatment, serotonin, dopamine, norepinephrine levels and event-related potential are measured. Compared with pre-treatment, the Montreal cognitive assessment and mini-mental state examination scores were significantly different after treatment (both p 0.05), and Montreal cognitive assessment and mini-mental state examination scores were significantly increased after treatment (both p 0.05), and serotonin, dopamine and norepinephrine were higher than the control group (p<0.01). The latency period of N2 and P3 was significantly prolonged, and the N2 and P3 incubation periods were significantly reduced, with significant differences (p<0.01). Sodium oligomannate capsules can improve the cognitive function of Parkinson's disease patients by regulating neurotransmitter levels, reducing N2 and P3 latency, improving short and delayed memory and directional force.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Indian Journal of Pharmaceutical Sciences.
Article · 21 Apr 2026
In silico molecular docking analysis of bioactive compounds from Kappaphycus alvarezii and Gracilaria debilis against BRCA1 protein
Article · 11 Mar 2026
Trimethoprim and Sulfamethoxazole-Loaded Nanoparticles Coated With Chitosan for Intranasal Delivery to Treat Cerebral Toxoplasmosis
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalIndian Journal of Pharmaceutical Sciences
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “G. Yin”
- BylineArticles whose byline prints “Xiaohui Hu”
- BylineArticles whose byline prints “Sanping Xie”
- BylineArticles whose byline prints “D. Gong”